These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35204713)

  • 1. Histone 2B Facilitates Plasminogen-Enhanced Endothelial Migration through Protease-Activated Receptor 1 (PAR1) and Protease-Activated Receptor 2 (PAR2).
    Das M; Ithychanda SS; Plow EF
    Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen-induced foam cell formation by macrophages occurs through a histone 2B (H2B)-PAR1 pathway and requires integrity of clathrin-coated pits.
    Izem L; Bialkowska K; Pluskota E; Das M; Das R; Nieman MT; Plow EF
    J Thromb Haemost; 2021 Apr; 19(4):941-953. PubMed ID: 33492784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells.
    Tripathi T; Abdi M; Alizadeh H
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3912-21. PubMed ID: 24876278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual blockade of protease-activated receptor 1 and 2 additively ameliorates diabetic kidney disease.
    Mitsui S; Oe Y; Sekimoto A; Sato E; Hashizume Y; Yamakage S; Kumakura S; Sato H; Ito S; Takahashi N
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1067-F1073. PubMed ID: 32200667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial reactive oxygen species: a common pathway for PAR1- and PAR2-mediated tissue factor induction in human endothelial cells.
    Banfi C; Brioschi M; Barbieri SS; Eligini S; Barcella S; Tremoli E; Colli S; Mussoni L
    J Thromb Haemost; 2009 Jan; 7(1):206-16. PubMed ID: 18983479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
    Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
    Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of the specificity of protease-activated receptors 1 and 2 signaling by factor Xa and thrombin.
    Rana S; Yang L; Hassanian SM; Rezaie AR
    J Cell Biochem; 2012 Mar; 113(3):977-84. PubMed ID: 22034092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for proteinase-activated receptor 2 and PKC-epsilon in thrombin-mediated induction of decay-accelerating factor on human endothelial cells.
    Lidington EA; Steinberg R; Kinderlerer AR; Landis RC; Ohba M; Samarel A; Haskard DO; Mason JC
    Am J Physiol Cell Physiol; 2005 Dec; 289(6):C1437-47. PubMed ID: 16079188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-2 (PAR2) mediates VEGF production through the ERK1/2 pathway in human glioblastoma cell lines.
    Dutra-Oliveira A; Monteiro RQ; Mariano-Oliveira A
    Biochem Biophys Res Commun; 2012 May; 421(2):221-7. PubMed ID: 22497886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
    McCoy KL; Traynelis SF; Hepler JR
    Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis.
    Shi X; Gangadharan B; Brass LF; Ruf W; Mueller BM
    Mol Cancer Res; 2004 Jul; 2(7):395-402. PubMed ID: 15280447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated-receptor-2 affects protease-activated-receptor-1-driven breast cancer.
    Jaber M; Maoz M; Kancharla A; Agranovich D; Peretz T; Grisaru-Granovsky S; Uziely B; Bar-Shavit R
    Cell Mol Life Sci; 2014 Jul; 71(13):2517-33. PubMed ID: 24177339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Protease-Activated Receptor (PAR) ligands: Parmodulins are reversible allosteric inhibitors of PAR1-driven calcium mobilization in endothelial cells.
    Gandhi DM; Majewski MW; Rosas R; Kentala K; Foster TJ; Greve E; Dockendorff C
    Bioorg Med Chem; 2018 May; 26(9):2514-2529. PubMed ID: 29685684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta.
    He RQ; Tang XF; Zhang BL; Li XD; Hong MN; Chen QZ; Han WQ; Gao PJ
    Biochem Biophys Res Commun; 2016 Apr; 473(2):517-23. PubMed ID: 27012211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence that protease-activated receptors mediate factor Xa signaling in endothelial cells.
    Camerer E; Kataoka H; Kahn M; Lease K; Coughlin SR
    J Biol Chem; 2002 May; 277(18):16081-7. PubMed ID: 11850418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial PAR2 activation evokes resistance artery relaxation.
    Zhang X; Lee MD; Buckley C; Hollenberg MD; Wilson C; McCarron JG
    J Cell Physiol; 2023 Apr; 238(4):776-789. PubMed ID: 36791026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protease-activated receptor (PAR) 1 but not PAR2 or PAR4 mediates endothelium-dependent relaxation to thrombin and trypsin in human pulmonary arteries.
    Hamilton JR; Moffatt JD; Frauman AG; Cocks TM
    J Cardiovasc Pharmacol; 2001 Jul; 38(1):108-19. PubMed ID: 11444493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct roles of protease-activated receptors in signal transduction regulation of endothelial nitric oxide synthase.
    Suzuki H; Motley ED; Eguchi K; Hinoki A; Shirai H; Watts V; Stemmle LN; Fields TA; Eguchi S
    Hypertension; 2009 Feb; 53(2):182-8. PubMed ID: 19064814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of protease-activated receptors in the human submucous plexus.
    Mueller K; Michel K; Krueger D; Demir IE; Ceyhan GO; Zeller F; Kreis ME; Schemann M
    Gastroenterology; 2011 Dec; 141(6):2088-2097.e1. PubMed ID: 21875497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR
    Grisaru-Granovsky S; Kumar Nag J; Zakar L; Rudina T; Lal Gupta C; Maoz M; Kozlova D; Bar-Shavit R
    FASEB J; 2020 Dec; 34(12):15701-15717. PubMed ID: 33136328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.